Four MRL Regulations that were recently adopted in the SCoPAFF Residues meeting entered the 2-month scrutiny period in the European Parliament (and Council).
DG SANTE published the agenda for the upcoming SCoPAFF Residues meeting on 13-14.02.2023.
EFSA published on 12.12.2022 a reasoned opinion on the MRLs for spirotetramat in herbs and edible flowers.
On 29.07.2022 two new Regulations were published in the Official Journal, amending MRLs in Regulation 396/2005.
On 16.05.2022 the scrutiny period started on an MRL draft Regulation.
On 28.03.2022 a Regulation was published, amending the approval periods of flubendiamide, L-ascorbic acid, spinetoram and spirotetramat.
The public minutes of the 22-23.02.2022 meeting of the SCoPAFF Residues was published.
In the Comitology Register, the first voting results for the written voting procedure of the SCoPAFF Legislation meeting of 27-28.02.2022 were uploaded.
On 04.02.2022 the agenda for the upcoming SCoPAFF Residues meeting of 22-23.02.2022 was published on the DG SANTE website.
The Dutch Ministery of Agriculture informed on 25.01.2022 the Dutch Parliament on its intentions for the SCoPAFF Legislation meeting of 27-28.01.2022.
On 25.01.2022 a Regulation was published, establishing MRLs for 9 substances.
EFSA published their scientific support for the EU, for the 52nd session of the CCPR (Codex meeting).
EFSA published a reasoned opinion on the setting of MRLs for spirotetramat for leeks, spring onions and honey.
On 16.04.2021 and 20.04.2021 three Regulations were published, amending the MRLs for benalaxyl, benalaxyl-M, dichlobenil, fluopicolide, proquinazid and pyridalyl (Reg 2021/616), for diclofop...
On 04.03.2021 DG SANTE published the short report on the SCoPAFF Legislation meeting of 22-23.10.2020.
On 10.12.2020 three draft resolutions were discussed and voted in the ENVI-Committee of the European Parliament.
deltamethrin, spirotetramat, Purpureocillium lilacinum strain PL 11
With the publication of a new implementing Regulation the approval periods of 55 substances are extended.
amidosulfuron, clomazone, daminozide , deltamethrin, deltamethrin, emamectin benzoate, fluoxastrobin, folpet, fosetyl, gibberellic acid, gibberellin, lenacil, mepiquat chloride, meptyldinocap...
In the European Parliament objections were logged in the scrutiny procedures of 3 new MRL Regulations.